Capstone Investment Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Capstone Investment Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-450,000	Closed	-$1.8M	–	1446
2019 Q4	$1.8M	Buy	+450,000	New	+$2.11M	0.01%	861
2017 Q2	–	Sell	-15,301	Closed	-$244K	–	1032
2017 Q1	$244K	Buy	+15,301	New	+$221K	0.01%	750
2016 Q4	–	Sell	-7,154	Closed	-$200K	–	1181
2016 Q3	$200K	Buy	+7,154	New	+$240K	﹤0.01%	688

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capstone Investment Advisors's DPLO Position: Q1 2020 in Review

Capstone Investment Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 450,000 shares — an estimated $1.8M sold.

Capstone Investment Advisors first reported a position in DPLO in Q3 2016 and held it in 3 quarters. The position peaked at $1.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Capstone Investment Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Capstone Investment Advisors sold 450,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.8M.
Capstone Investment Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 3 quarters.
Capstone Investment Advisors's DIPLOMAT PHARMACY, INC. position peaked at $1.8M in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.